Leerink Partnrs Weighs in on Cardinal Health, Inc.’s FY2026 Earnings (NYSE:CAH)

Cardinal Health, Inc. (NYSE:CAHFree Report) – Stock analysts at Leerink Partnrs lowered their FY2026 EPS estimates for shares of Cardinal Health in a report issued on Monday, April 22nd. Leerink Partnrs analyst M. Cherny now expects that the company will post earnings of $8.48 per share for the year, down from their prior estimate of $9.19. Leerink Partnrs currently has a “Outperform” rating on the stock. The consensus estimate for Cardinal Health’s current full-year earnings is $7.28 per share. Leerink Partnrs also issued estimates for Cardinal Health’s FY2027 earnings at $9.38 EPS and FY2028 earnings at $10.50 EPS.

A number of other equities research analysts have also commented on CAH. SVB Leerink assumed coverage on shares of Cardinal Health in a report on Monday, February 26th. They set an “outperform” rating and a $125.00 price target for the company. Argus upgraded shares of Cardinal Health from a “hold” rating to a “buy” rating in a report on Friday, February 9th. Barclays began coverage on shares of Cardinal Health in a report on Wednesday, January 3rd. They issued an “overweight” rating and a $117.00 price objective for the company. StockNews.com lowered shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a report on Wednesday. Finally, UBS Group upped their price objective on shares of Cardinal Health from $122.00 to $125.00 and gave the stock a “buy” rating in a report on Monday, February 5th. One analyst has rated the stock with a sell rating, three have issued a hold rating and eight have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $103.07.

Read Our Latest Research Report on CAH

Cardinal Health Stock Up 0.2 %

NYSE:CAH opened at $103.54 on Wednesday. The company has a fifty day moving average of $109.56 and a 200 day moving average of $104.59. Cardinal Health has a 52 week low of $77.56 and a 52 week high of $116.04. The firm has a market capitalization of $25.18 billion, a P/E ratio of 40.76, a P/E/G ratio of 0.99 and a beta of 0.68.

Cardinal Health (NYSE:CAHGet Free Report) last announced its quarterly earnings data on Thursday, February 1st. The company reported $1.82 earnings per share for the quarter, topping analysts’ consensus estimates of $1.56 by $0.26. Cardinal Health had a net margin of 0.30% and a negative return on equity of 57.44%. The firm had revenue of $57.45 billion during the quarter, compared to analyst estimates of $57.02 billion. During the same period in the previous year, the business posted $1.32 EPS. The business’s quarterly revenue was up 11.6% on a year-over-year basis.

Cardinal Health Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, April 15th. Stockholders of record on Monday, April 1st were given a $0.5006 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.93%. The ex-dividend date was Thursday, March 28th. Cardinal Health’s dividend payout ratio is presently 78.74%.

Institutional Trading of Cardinal Health

A number of hedge funds and other institutional investors have recently modified their holdings of the business. V Square Quantitative Management LLC grew its position in shares of Cardinal Health by 12.6% in the 1st quarter. V Square Quantitative Management LLC now owns 8,919 shares of the company’s stock worth $998,000 after buying an additional 1,000 shares during the period. Simplicity Wealth LLC purchased a new stake in Cardinal Health during the 1st quarter valued at about $747,000. Archford Capital Strategies LLC purchased a new stake in Cardinal Health during the 1st quarter valued at about $213,000. Spire Wealth Management grew its position in Cardinal Health by 309.1% during the 1st quarter. Spire Wealth Management now owns 2,205 shares of the company’s stock valued at $247,000 after purchasing an additional 1,666 shares during the last quarter. Finally, Assenagon Asset Management S.A. grew its position in Cardinal Health by 61.6% during the 1st quarter. Assenagon Asset Management S.A. now owns 9,494 shares of the company’s stock valued at $1,062,000 after purchasing an additional 3,618 shares during the last quarter. 87.17% of the stock is owned by hedge funds and other institutional investors.

Cardinal Health Company Profile

(Get Free Report)

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

See Also

Earnings History and Estimates for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.